What you need to know
Drug maker Sandoz Inc. is recalling one lot of its Losartan Potassium Hydrochlorothiazide Tablets because the pills may have been contaminated with trace amounts of N-nitrosodiethylamine (NDEA), a known carcinogen. To date, no adverse events have been reported.
The following Losartan pills are affected:
- Losartan Potassium Hydrochlorothiazide
- 100 mg or 25 mg tablets in 1,000-count plastic bottles
- NDC: 0781-5207-10
- Lot number: JB8912
- Expiration date: 06/2020
- Distributed after October 8, 2018
For more information
Contact Sandoz Inc. at 1-800-525-8747 Monday-Friday 8:30 a.m. – 5:00 p.m. (EST).